| Bioactivity | STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1]. | ||||||||||||
| Name | STING agonist-20 | ||||||||||||
| CAS | 2591300-72-8 | ||||||||||||
| Formula | C36H39N11O8 | ||||||||||||
| Molar Mass | 753.76 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Jeremy R. DUVALL, et al. Sting agonist compounds and methods of use. US20210032269. |
STING agonist-20
CAS: 2591300-72-8 F: C36H39N11O8 W: 753.76
STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.